Drugs can take a decade of research and over a billion dollars' worth of development before they reach the market. Resources are wasted in the pre-discovery phase through a trial and error process that yields more error than success.
There are hidden insights in biomedical data, waiting to be discovered and to lead towards promising drug candidates.
Unfortunately, these patterns are too complex and diffuse to be detected by the human mind; this is where a more powerful solution comes in – Standigm’s latest artificial intelligence technologies.